Arthur Allen - KFF Health News
-
As the country faces a rise in infections driven by the BA.5 subvariant, about 70% of people 50 and older who got a first booster shot haven't received the recommended second one, according to the CDC.
-
The drugmaker has the best-selling vaccine to prevent COVID and the most effective drug to treat it. Its success and might have overshadowed the government’s COVID-fighting strategy.
-
After years of failure, the Maryland company aims to attract the vaccine-hesitant with an alternative to mRNA shots. But will it find a market?
-
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for COVID. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
-
A corporate CEO’s call for a fourth mRNA shot struck those closely watching the pandemic as self-serving. It creates public pressure for a fourth dose of vaccine before government experts have time to assess the evidence and settle on the best course forward.
-
An epic battle is playing out behind the scenes over whether the government should pay for Aduhelm, an FDA-approved Alzheimer’s drug that scientists say has not been proven to work.
-
As scientists argue whether a previous bout of COVID-19 voffers the same amount of protection as vaccinations, people turn to the courts to decide.
-
A CDC advisory committee is set to discuss a possible link between the vaccine and heart-related side effects in youths, and whether it merits changing recommendations for vaccinating teenagers.
-
President Biden has ordered intelligence agencies to determine where the coronavirus originated, but China is bucking demands to let investigators see more. Can this probe lead to anything positive?
-
Leading virologists, including Dr. Anthony Fauci, are demanding a deeper probe into China’s Wuhan Institute of Virology as they try to identify the source of the deadly coronavirus.